| Sep 26 |
CervoMed to Deliver Late-Breaking Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)
|
| Sep 21 |
With 35% ownership, insiders at CervoMed Inc. (NASDAQ:CRVO) are pretty optimistic and have been buying recently
|
| Sep 20 |
CERVOMED INC (CRVO) Soars 10.6%: Is Further Upside Left in the Stock?
|
| Aug 27 |
CervoMed to Participate in Upcoming Investor Conferences
|
| Aug 22 |
CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies
|
| Aug 12 |
CervoMed GAAP EPS of -$0.27, revenue of $3.29M
|
| Aug 12 |
CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
|
| Aug 11 |
CervoMed Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 4 |
Morgan Stanley Predicts up to ~230% Surge for These 2 ‘Strong Buy’ Stocks
|
| Jul 30 |
CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference
|
